LSA
RARE icon

Leonteq Securities AG’s Ultragenyx Pharmaceutical RARE Stock Holding History

Leonteq Securities AG’s Portfolio RARE Stock Details RARE Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2026
Q2 		$9.75K Sell
292
-1,503
-84% -$37.3K ﹤0.01% 1028
2026
Q1 		$37.6K Buy
1,795
+1,333
+289% +$30K ﹤0.01% 900
2025
Q4 		$10.6K Sell
462
-25
-5% -$822 ﹤0.01% 1188
2025
Q3 		$14.6K Sell
487
-11,513
-96% -$345K ﹤0.01% 1077
2025
Q2 		$436K Buy
+12,000
New +$433K 0.02% 415
2025
Q1 		– Sell
-1,510
Closed -$63.5K – 1325
2024
Q4 		$63.5K Buy
+1,510
New +$74.9K ﹤0.01% 784
2024
Q2 		– Sell
-124
Closed -$5.79K – 1279
2024
Q1 		$5.79K Sell
124
-393
-76% -$18.5K ﹤0.01% 1064
2023
Q4 		$24.7K Sell
517
-1,057
-67% -$41K ﹤0.01% 912
2023
Q3 		$56.1K Buy
1,574
+574
+57% +$22.7K ﹤0.01% 782
2023
Q2 		$46.1K Sell
1,000
-300
-23% -$13.9K ﹤0.01% 841
2023
Q1 		$52.1K Hold
1,300
– – ﹤0.01% 792
2022
Q4 		$60.2K Hold
1,300
– – ﹤0.01% 784
2022
Q3 		$53.8K Hold
1,300
– – ﹤0.01% 792
2022
Q2 		$77.6K Hold
1,300
– – ﹤0.01% 734
2022
Q1 		$94.4K Buy
1,300
+1,000
+333% +$69.6K ﹤0.01% 746
2021
Q4 		$25.2K Buy
+300
New +$24.4K ﹤0.01% 1009
2021
Q2 		– Sell
-2,244
Closed -$256K – 1118
2021
Q1 		$256K Sell
2,244
-257
-10% -$35K 0.02% 515
2020
Q4 		$346K Buy
+2,501
New +$297K 0.02% 475

Other funds holding RARE

BlackRock
BlackRock New York $6.73T AUM 46.02% 1-Year Est. Return
RI
RTW Investments New York $11.7B AUM 174.13% 1-Year Est. Return
Vanguard Portfolio Management
Vanguard Portfolio Management Malvern, Pennsylvania $2.22T AUM
AQR Capital Management
AQR Capital Management Greenwich, Connecticut $287B AUM 42.33% 1-Year Est. Return
State Street
State Street Boston, Massachusetts $3.37T AUM 44.26% 1-Year Est. Return
Vanguard Capital Management
Vanguard Capital Management Malvern, Pennsylvania $4.68T AUM
Two Sigma Investments
Two Sigma Investments New York $138B AUM 41.87% 1-Year Est. Return
Sands Capital Management
Sands Capital Management Arlington, Virginia $26.9B AUM 34.44% 1-Year Est. Return
Jacobs Levy Equity Management
Jacobs Levy Equity Management Florham Park, New Jersey $27.8B AUM 46.46% 1-Year Est. Return
FCM
Frontier Capital Management Boston, Massachusetts $10.7B AUM 67.78% 1-Year Est. Return

Leonteq Securities AG's RARE Position: Q2 2026 in Review

Leonteq Securities AG reduced its Ultragenyx Pharmaceutical (RARE) stake by 84% in Q2 2026, selling an estimated $37.3K and leaving 292 shares worth $9.75K. The position accounts for ﹤0.01% of the portfolio, ranked #1028.

Leonteq Securities AG first reported a position in RARE in Q4 2020 and has held it in 18 quarters since. The position peaked at $436K in Q2 2025. 310 funds tracked by Wall St. Rank hold RARE as of Q2 2026.

  • Leonteq Securities AG held 292 shares of Ultragenyx Pharmaceutical worth $9.75K as of Q2 2026.
  • Leonteq Securities AG sold 1,503 Ultragenyx Pharmaceutical shares in Q2 2026, an estimated $37.3K.
  • Ultragenyx Pharmaceutical made up ﹤0.01% of Leonteq Securities AG's portfolio in Q2 2026, its #1028 holding.
  • Leonteq Securities AG first reported a position in Ultragenyx Pharmaceutical in Q4 2020 and has held it in 18 quarters since.
  • Leonteq Securities AG's Ultragenyx Pharmaceutical position peaked at $436K in Q2 2025.
  • 310 funds tracked by Wall St. Rank held Ultragenyx Pharmaceutical as of Q2 2026.

Based on Leonteq Securities AG's 13F filing for Q2 2026, filed 27 Jul 2026.